Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
J Med Case Rep
; 10(1): 236, 2016 Aug 24.
Article
in En
| MEDLINE
| ID: mdl-27557810
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Immunoglobulin G
/
B-Lymphocytes
/
Epstein-Barr Virus Infections
/
Rituximab
/
Immunologic Factors
/
Lymphoproliferative Disorders
Type of study:
Risk_factors_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Med Case Rep
Year:
2016
Type:
Article
Affiliation country:
Japan